Bicycle Therapeutics (BCYC) Statistics & Valuation Metrics - Stocknear

Bicycle Therapeutics

NASDAQ: BCYC · Real-Time Price · USD
7.13
0.16 (2.30%)
At close: Sep 05, 2025, 3:04 PM

Bicycle Therapeutics Statistics

Share Statistics

Bicycle Therapeutics has 69.25M shares outstanding. The number of shares has increased by 0.38% in one year.

69.25M
0.38%
0.2%
60.31%
61.22M
3,398
1.22%

Short Selling Information

The latest short interest is 1.65M, so 2.37% of the outstanding shares have been sold short.

1.65M
2.37%
4.28%
5.76

Valuation Ratios

The PE ratio is -4.82 and the forward PE ratio is -1.66. Bicycle Therapeutics's PEG ratio is 0.11.

-4.82
-1.66
23.1
15.6
1.03
-4.91
0.11
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Bicycle Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 13.81, with a Debt / Equity ratio of 0.01.

13.81
13.81
0.01
-0.06
-0.06
-121.31

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$115.66K
$-554.2K
305
0.04
n/a

Taxes

-4.76M
2.74%

Stock Price Statistics

The stock price has increased by -65.88% in the last 52 weeks. The beta is 1.45, so Bicycle Therapeutics's price volatility has been higher than the market average.

1.45
-65.88%
7.65
10.7
38.58
277,437

Income Statement

In the last 12 months, Bicycle Therapeutics had revenue of 35.27M and earned -169.03M in profits. Earnings per share was -2.91.

35.27M
-137.69M
-209.87M
-169.03M
-164.89M
-172.07M
-2.91
Full Income Statement

Balance Sheet

The company has 879.52M in cash and 9.49M in debt, giving a net cash position of 870.03M.

879.52M
9.49M
870.03M
-680.79M
832.18M
726.84M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -164.72M and capital expenditures -1.24M, giving a free cash flow of -165.96M.

-164.72M
-1.24M
-165.96M
-2.85
Full Cash Flow Statement

Margins

Gross margin is -390.34%, with operating and profit margins of -594.96% and -479.18%.

-390.34%
-594.96%
-492.69%
-479.18%
-467.45%
-594.96%
-470.47%

Dividends & Yields

BCYC does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for BCYC is $20, which is 186.9% higher than the current price. The consensus rating is "Buy".

$20
186.9%
Buy
11
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

0.49
3